Year archive

PolyPeptide Group AG — 2023 filings

All 29 regulatory filings released by PolyPeptide Group AG (PPGN) in 2023, sourced directly from the official regulator.

29 Filings

2023 Period

2023 filings (29)

Filing	Released	Lang
PolyPeptide signs scientific collaboration agreement Regulatory Filings	2023-10-31	English
PolyPeptide signs scientific collaboration agreement Environmental & Social Information	2023-10-31	English
PolyPeptide unterzeichnet wissenschaftliche Kollaborationsvereinbarung Environmental & Social Information	2023-10-31	German
PolyPeptide secures revolving credit facility Capital/Financing Update	2023-10-02	English
PolyPeptide secures revolving credit facility Capital/Financing Update	2023-10-02	English
PolyPeptide sichert revolvierende Kreditfazilität Capital/Financing Update	2023-10-02	German
Transformational progress taking shape, profitability impacted by rapid expansion appointment of Marc Augustin as new CFO Earnings Release H1 2023	2023-08-15	English
Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO Interim / Quarterly Report H1 2023	2023-08-15	English
Transformation nimmt Gestalt an, rasche Expansion belastet Profitabilität – Ernennung von Marc Augustin zum neuen CFO Earnings Release H1 2023	2023-08-15	German
PolyPeptide delivers revenue of around EUR 132 million for H1 expects net loss for H1 and full year 2023 Earnings Release H1 2023	2023-07-13	English
PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023 Earnings Release H1 2023	2023-07-13	English
PolyPeptide erzielt Umsatz von rund EUR 132 Millionen im H1 und erwartet Nettoverlust für das H1 und das Gesamtjahr 2023 Earnings Release H1 2023	2023-07-13	German
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs Regulatory Filings	2023-05-09	English
PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs Regulatory Filings	2023-05-09	English
PolyPeptide und Numaferm beschliessen Partnerschaft zur nachhaltigeren Produktion peptidbasierter pharmazeutischer Wirkstoffe Regulatory Filings	2023-05-09	German
PolyPeptide announces results of the annual General Meeting 2023 AGM Information	2023-04-12	English
PolyPeptide announces results of the annual General Meeting 2023 AGM Information	2023-04-12	English
PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2023 bekannt AGM Information	2023-04-12	German
PolyPeptide appoints Juan-Jose Gonzalez as CEO and announces change of CFO Board/Management Information	2023-04-03	English
PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO Board/Management Information	2023-04-03	English
PolyPeptide ernennt Juan-José Gonzalez zum CEO und meldet Wechsel des CFO Board/Management Information	2023-04-03	German
PolyPeptide publishes invitation to the annual General Meeting 2023 AGM Information	2023-03-22	English
PolyPeptide publishes invitation to the annual General Meeting 2023 AGM Information	2023-03-22	English
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2023 AGM Information	2023-03-22	German
PolyPeptide reports weaker performance in 2022 expects growth to recover in the second half of 2023 Earnings Release FY 2022	2023-03-14	English
PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023 Earnings Release FY 2022	2023-03-14	English
PolyPeptide meldet schwächere Performance im Jahr 2022 – erwartet Wachstum im zweiten Halbjahr 2023 Earnings Release FY 2022	2023-03-14	German
Annual Report 2022 Annual Report FY 2022	2023-03-09	English
PolyPeptide: CEO of PolyPeptide resigns Board/Management Information	2023-01-30	English